Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin

NCT00668850 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Generex Oral-lyn™
DRUG: Regular human insulin

Sponsor

Generex Biotechnology Corp.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]